Literature DB >> 24535531

Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.

R Bellomo, J Bion, S Finfer, J Myburgh, A Perner, K Reinhart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535531     DOI: 10.1093/bja/aeu025

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  5 in total

1.  White paper: statement on conflicts of interest.

Authors:  Julian Bion; Massimo Antonelli; LLuis Blanch; J Randall Curtis; Christiane Druml; Bin Du; Flavia R Machado; Charles Gomersall; Christiane Hartog; Mitchell Levy; John Myburgh; Gordon Rubenfeld; Charles Sprung
Journal:  Intensive Care Med       Date:  2018-09-06       Impact factor: 17.440

2.  Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study.

Authors:  Toko Fukushima; Shigehiko Uchino; Tomoko Fujii; Masanori Takinami; Shoichi Uezono
Journal:  J Anesth       Date:  2017-03-24       Impact factor: 2.078

3.  Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.

Authors:  Mathias Opperer; Jashvant Poeran; Rehana Rasul; Madhu Mazumdar; Stavros G Memtsoudis
Journal:  BMJ       Date:  2015-03-27

4.  Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency.

Authors:  Christian J Wiedermann; Klaus Eisendle
Journal:  J Pharm Policy Pract       Date:  2017-03-21

Review 5.  Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union.

Authors:  Katja-Nicole Adamik; Ivayla D Yozova
Journal:  Front Vet Sci       Date:  2019-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.